KROS / Keros Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Keros Therapeutics, Inc.
US ˙ NasdaqGM ˙ US4923271013

Utestående aktier 40,615,414 shares
Insideraktier6 952 710 shares
Insynsägande17,12 %
Totalt antal insynspersoner24
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

0 ( )

5164 out of 11304

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

0.000 %( )

5133 out of 11220

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

Keros Therapeutics, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
ADAR1 Capital Management, LLC 10% Owner - [10%] 743 358 743 358
Arkin Bio Ventures Limited Partnership 10% Owner - [10%] 2 013 102 2 013 102
Moshe Arkin 10% Owner - [10%] 2 013 102 2 013 102
Jean Jacques Bienaime Director - [D] 5 450 5 450
Chyung Yung H. Chief Medical Officer - [O] 44 000 44 000
Esther Cho SVP, General Counsel - [O] 88 000 88 000
Simon Peter Cooper 50 000
Nima Farzan Director - [D] 5 250 5 250
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Carl L Gordon Director - [D] 5 250 5 250
Mary Ann Gray Director - [D] 5 250 5 250
Tomer Kariv Director, 10% Owner - [D] [10%] 5 250 5 250
Julius Knowles Director - [D] 6 441 6 441
Jennifer Lachey Chief Scientific Officer - [O] 95 100 95 100
Alon Lazarus Director, 10% Owner - [D] [10%] 2 013 102 2 013 102
Lorena Raquel Lerner Chief Science Officer - [O] 70 000 70 000
Ran Nussbaum Director, 10% Owner - [D] [10%] 5 250 5 250
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Orbimed Advisors Llc Director - [D] 119 522 119 522
Claudia Ordonez Chief Medical Officer - [O] 0 0
Pontifax Late Stage GP Ltd. 10% Owner - [10%] 155 262 1 226 412
Pontifax Management 4 G.P. (2015) Ltd. 10% Owner - [10%] 1 226 412 1 226 412
Keith Regnante CHIEF FINANCIAL OFFICER - [O] 44 000 44 000
Christopher Rovaldi Chief Operating Officer - [O] 60 000 60 000
Jasbir Seehra CHIEF EXECUTIVE OFFICER, Director - [D] [O] 392 723 392 723
Alpna Seth Director - [D] 5 250 5 250

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i KROS / Keros Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Max
Pris vid
Max
Maximal
vinst ($)
Maximal avkastning (%)
2025-04-09 ADAR1 Capital Management, LLC 18 560 9,3952 18 560 9,3952 174 375 162 16.0400 123 328 70,73
2025-04-09 ADAR1 Capital Management, LLC 16 365 9,3952 16 365 9,3952 153 752
2025-04-09 ADAR1 Capital Management, LLC 325 000 9,8570 325 000 9,8570 3 203 525
2025-04-09 ADAR1 Capital Management, LLC 500 000 10,3300 500 000 10,3300 5 165 000
2025-04-09 ADAR1 Capital Management, LLC 74 333 10,3300 74 333 10,3300 767 860
2020-11-17 Pontifax Management 4 G.P. (2015) Ltd. 6 000 50,0000 6 000 50,0000 300 000
2020-11-17 Pontifax Management 4 G.P. (2015) Ltd. 14 400 50,0000 14 400 50,0000 720 000
2020-11-17 Pontifax Management 4 G.P. (2015) Ltd. 12 966 50,0000 12 966 50,0000 648 300
2020-11-17 Pontifax Management 4 G.P. (2015) Ltd. 26 634 50,0000 26 634 50,0000 1 331 700

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

KROS / Keros Therapeutics, Inc. Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i KROS / Keros Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Min
Pris vid
Min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2024-08-13 ORBIMED ADVISORS LLC 29 400 44,0100 29 400 44,0100 1 293 894 231 9.5500 −1 013 124 −78,30
2024-08-13 ORBIMED ADVISORS LLC 220 600 44,0100 220 600 44,0100 9 708 606

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

KROS / Keros Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum
Handel
datum
Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris
Enheter
ändrad
Värde
ändrad (1K)
Kvarvarande
Optioner
Kvarvarande
Aktier
2025-09-05 2025-09-03 4 Seehra Jasbir KROS Common Stock A - Award D 90 500 392 723
2025-08-15 3 Lerner Lorena Raquel KROS Common Stock D 35 000
2025-08-15 3 Cho Esther KROS Common Stock D 44 000
2025-06-24 2025-06-20 4 ADAR1 Capital Management, LLC By Spearhead Insurance Solutions IDF, LLC KROS Common Stock X - Other I 70,0000 −200 −14 743 358
2025-06-24 2025-06-20 4 ADAR1 Capital Management, LLC By ADAR1 Partners, LP KROS Common Stock X - Other I 70,0000 −1 400 −98 4 391 237
2025-06-24 2025-06-20 4 ADAR1 Capital Management, LLC By ADAR1 Partners, LP KROS Common Stock X - Other I 60,0000 −100 −6 4 392 637
2025-06-06 2025-06-04 4 GRAY MARY ANN KROS Common Stock A - Award D 5 250 5 250
2025-06-06 2025-06-04 4 BIENAIME JEAN JACQUES KROS Common Stock A - Award D 5 250 5 450
2025-06-06 2025-06-04 4 Seth Alpna KROS Common Stock A - Award D 5 250 5 250
2025-06-06 2025-06-04 4 Nussbaum Ran KROS Common Stock A - Award D 5 250 5 250
2025-06-06 2025-06-04 4 Kariv Tomer KROS Common Stock A - Award D 5 250 5 250
2025-06-06 2025-06-04 4 Farzan Nima KROS Common Stock A - Award D 5 250 5 250
2025-06-06 2025-06-04 4 GORDON CARL L KROS Common Stock A - Award D 5 250 5 250
2025-06-06 2025-06-04 4 Knowles Julius KROS Common Stock A - Award D 5 250 6 441
2025-04-11 2025-04-09 4 ADAR1 Capital Management, LLC By ADAR1 Partners, LP KROS Common Stock P - Purchase I 10,3300 74 333 768 4 392 737
2025-04-11 2025-04-09 4 ADAR1 Capital Management, LLC By ADAR1 Partners, LP KROS Common Stock P - Purchase I 10,3300 500 000 5 165 4 318 404
2025-04-11 2025-04-09 4 ADAR1 Capital Management, LLC By ADAR1 Partners, LP KROS Common Stock P - Purchase I 9,8570 325 000 3 204 3 818 404
2025-04-11 2025-04-09 4 ADAR1 Capital Management, LLC By Spearhead Insurance Solutions IDF, LLC KROS Common Stock P - Purchase I 9,3952 16 365 154 743 558
2025-04-11 2025-04-09 4 ADAR1 Capital Management, LLC By ADAR1 Partners, LP KROS Common Stock P - Purchase I 9,3952 18 560 174 3 493 404
2025-04-11 3 ADAR1 Capital Management, LLC By ADAR1 SPV I, LP KROS Common Stock I 254 669
2025-04-11 3 ADAR1 Capital Management, LLC By ADAR1 Partners, LP KROS Common Stock I 3 474 844
2025-04-11 3 ADAR1 Capital Management, LLC By Spearhead Insurance Solutions IDF, LLC KROS Common Stock I 727 193
2025-04-07 2025-04-04 4 Seehra Jasbir KROS Common Stock M - Exercise D 0,3000 49 367 15 302 223
2025-02-19 2025-02-18 4 Rovaldi Christopher KROS Common Stock A - Award D 60 000 60 000
2025-02-19 2025-02-18 4 Regnante Keith KROS Common Stock A - Award D 44 000 44 000
2025-02-19 2025-02-18 4 CHYUNG YUNG H. KROS Common Stock A - Award D 44 000 44 000
2025-01-24 2024-01-04 4/A Regnante Keith KROS Common Stock S - Sale D 45,2900 −40 000 −1 812 0
2025-01-24 2024-01-04 4/A Regnante Keith KROS Common Stock M - Exercise D 16,0000 40 000 640 40 000
2024-08-15 2024-08-13 4 GORDON CARL L See footnotes KROS Common Stock S - Sale I 44,0100 −29 400 −1 294 119 522
2024-08-15 2024-08-13 4 GORDON CARL L See footnotes KROS Common Stock S - Sale I 44,0100 −220 600 −9 709 899 212
2024-08-15 2024-08-13 4 ORBIMED ADVISORS LLC See footnotes KROS Common Stock S - Sale I 44,0100 −29 400 −1 294 119 522
2024-08-15 2024-08-13 4 ORBIMED ADVISORS LLC See footnotes KROS Common Stock S - Sale I 44,0100 −220 600 −9 709 899 212
2024-06-05 3 BIENAIME JEAN JACQUES KROS Common Stock D 200
2024-01-08 2023-11-04 4 Regnante Keith KROS Common Stock S - Sale D 45,2900 −40 000 −1 812 0
2024-01-08 2023-11-04 4 Regnante Keith KROS Common Stock M - Exercise D 16,0000 40 000 640 40 000
2023-06-12 2023-06-09 4 Regnante Keith KROS Common Stock S - Sale D 47,2500 −2 579 −122 0
2023-06-12 2023-06-09 4 Regnante Keith KROS Common Stock S - Sale D 46,4600 −1 428 −66 2 579
2023-06-12 2023-06-09 4 Regnante Keith KROS Common Stock S - Sale D 45,0300 −15 993 −720 4 007
2023-06-12 2023-06-09 4 Regnante Keith KROS Common Stock M - Exercise D 16,0000 20 000 320 20 000
2023-06-12 2023-06-08 4 Regnante Keith KROS Common Stock S - Sale D 48,6500 −2 699 −131 0
2023-06-12 2023-06-08 4 Regnante Keith KROS Common Stock S - Sale D 47,6600 −17 301 −825 2 699
2023-06-12 2023-06-08 4 Regnante Keith KROS Common Stock M - Exercise D 16,0000 20 000 320 20 000
2023-04-11 2023-04-08 4 Seehra Jasbir KROS Common Stock M - Exercise D 0,4800 4 000 2 252 856
2023-01-20 2020-04-13 4 Knowles Julius KROS Common Stock P - Purchase D 20,9800 1 191 25 1 191
2022-11-30 2022-11-29 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock X - Other I 0,0001 −1 914 −0 1 226 412
2022-11-30 2022-11-29 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock X - Other I 0,0001 −1 723 −0 1 121 045
2022-11-30 2022-11-29 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock X - Other I 0,0001 −3 539 −0 2 284 612
2022-11-30 2022-11-29 4 Nussbaum Ran KROS Common Stock X - Other I 0,0001 −1 914 −0 1 226 412
2022-11-30 2022-11-29 4 Nussbaum Ran KROS Common Stock X - Other I 0,0001 −1 723 −0 1 121 045
2022-11-30 2022-11-29 4 Nussbaum Ran KROS Common Stock X - Other I 0,0001 −3 539 −0 2 284 612
2022-11-30 2022-11-29 4 Kariv Tomer KROS Common Stock X - Other I 0,0001 −1 914 −0 1 226 412
2022-11-30 2022-11-29 4 Kariv Tomer KROS Common Stock X - Other I 0,0001 −1 723 −0 1 121 045
2022-11-30 2022-11-29 4 Kariv Tomer KROS Common Stock X - Other I 0,0001 −3 539 −0 2 284 612
2022-07-19 2022-07-15 4 Lachey Jennifer KROS Common Stock S - Sale D 30,0000 −46 034 −1 381 95 100
2022-07-19 2022-07-15 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 46 034 14 141 134
2022-07-15 2022-07-13 4 Lachey Jennifer KROS Common Stock S - Sale D 30,0000 −1 916 −57 95 100
2022-07-15 2022-07-13 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 1 916 1 93 184
2022-06-14 2022-06-14 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 9 400 3 95 100
2022-06-10 2022-06-09 4 Seehra Jasbir KROS Common Stock M - Exercise D 0,3000 5 000 2 248 856
2022-05-13 2022-05-11 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −5 300 66 105
2022-05-13 2022-05-11 4 Lachey Jennifer KROS Common Stock S - Sale D 45,4500 −16 −1 85 700
2022-05-13 2022-05-11 4 Lachey Jennifer KROS Common Stock S - Sale D 44,2300 −223 −10 85 716
2022-05-13 2022-05-11 4 Lachey Jennifer KROS Common Stock S - Sale D 43,3200 −719 −31 85 939
2022-05-13 2022-05-11 4 Lachey Jennifer KROS Common Stock S - Sale D 42,4900 −944 −40 86 658
2022-05-13 2022-05-11 4 Lachey Jennifer KROS Common Stock S - Sale D 41,2600 −3 398 −140 87 602
2022-05-13 2022-05-11 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 5 300 2 91 000
2022-04-13 2022-04-11 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −5 300 71 405
2022-04-13 2022-04-11 4 Lachey Jennifer KROS Common Stock S - Sale D 64,1500 −559 −36 85 700
2022-04-13 2022-04-11 4 Lachey Jennifer KROS Common Stock S - Sale D 63,5000 −2 315 −147 86 259
2022-04-13 2022-04-11 4 Lachey Jennifer KROS Common Stock S - Sale D 62,3200 −1 009 −63 88 574
2022-04-13 2022-04-11 4 Lachey Jennifer KROS Common Stock S - Sale D 61,3700 −1 417 −87 89 583
2022-04-13 2022-04-11 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 5 300 2 91 000
2022-04-08 2022-04-06 4 Rovaldi Christopher KROS Employee Stock Option (right to buy) M - Exercise D 16,00 −1 728 8 002
2022-04-08 2022-04-06 4 Rovaldi Christopher KROS Common Stock S - Sale D 65,0000 −1 728 −112 0
2022-04-08 2022-04-06 4 Rovaldi Christopher KROS Common Stock M - Exercise D 16,0000 1 728 28 1 728
2022-04-06 2022-04-04 4 Lachey Jennifer KROS of Shares Employee Stock Option (right to buy) M - Exercise D 0,30 −7 950 76 705
2022-04-06 2022-04-04 4 Lachey Jennifer KROS Common Stock S - Sale D 60,0000 −7 950 −477 85 700
2022-04-06 2022-04-04 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 7 950 2 93 650
2022-04-05 2022-04-01 4 Rovaldi Christopher KROS Employee Stock Option (right to buy) M - Exercise D 16,00 −864 9 730
2022-04-05 2022-04-01 4 Rovaldi Christopher KROS Common Stock S - Sale D 58,8300 −105 −6 0
2022-04-05 2022-04-01 4 Rovaldi Christopher KROS Common Stock S - Sale D 57,9700 −366 −21 105
2022-04-05 2022-04-01 4 Rovaldi Christopher KROS Common Stock S - Sale D 56,8900 −287 −16 471
2022-04-05 2022-04-01 4 Rovaldi Christopher KROS Common Stock S - Sale D 56,2000 −104 −6 758
2022-04-05 2022-04-01 4 Rovaldi Christopher KROS Common Stock S - Sale D 54,3400 −2 −0 862
2022-04-05 2022-04-01 4 Rovaldi Christopher KROS Common Stock M - Exercise D 16,0000 864 14 864
2022-03-15 2022-03-11 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −2 650 84 655
2022-03-15 2022-03-11 4 Lachey Jennifer KROS Common Stock S - Sale D 54,5400 −875 −48 85 700
2022-03-15 2022-03-11 4 Lachey Jennifer KROS Common Stock S - Sale D 53,3600 −713 −38 86 575
2022-03-15 2022-03-11 4 Lachey Jennifer KROS Common Stock S - Sale D 52,4300 −1 062 −56 87 288
2022-03-15 2022-03-11 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 2 650 1 88 350
2022-02-15 2022-02-11 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −2 650 87 305
2022-02-15 2022-02-11 4 Lachey Jennifer KROS Common Stock S - Sale D 53,1000 −199 −11 85 700
2022-02-15 2022-02-11 4 Lachey Jennifer KROS Common Stock S - Sale D 52,3500 −1 378 −72 85 899
2022-02-15 2022-02-11 4 Lachey Jennifer KROS Common Stock S - Sale D 51,5000 −1 073 −55 87 277
2022-02-15 2022-02-11 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 2 650 1 88 350
2022-02-03 2022-02-01 4 Rovaldi Christopher KROS Employee Stock Option (right to buy) A - Award D 49,34 100 000 100 000
2022-01-25 2022-01-21 4 Seehra Jasbir KROS Employee Stock Option (right to buy) A - Award D 46,30 165 000 165 000
2022-01-25 2022-01-21 4 Regnante Keith KROS Employee Stock Option (right to buy) A - Award D 46,30 50 000 50 000
2022-01-25 2022-01-21 4 Lachey Jennifer KROS Employee Stock Option (right to buy) A - Award D 46,30 50 000 50 000
2022-01-25 2022-01-21 4 Cooper Simon Peter KROS Employee Stock Option (right to buy) A - Award D 46,30 50 000 50 000
2022-01-13 2022-01-11 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −2 650 89 955
2022-01-13 2022-01-11 4 Lachey Jennifer KROS Common Stock S - Sale D 54,4500 −1 134 −62 85 700
2022-01-13 2022-01-11 4 Lachey Jennifer KROS Common Stock S - Sale D 53,5600 −1 196 −64 86 834
2022-01-13 2022-01-11 4 Lachey Jennifer KROS Common Stock S - Sale D 52,0100 −320 −17 88 030
2022-01-13 2022-01-11 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 2 650 1 88 350
2022-01-07 2022-01-05 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −2 650 92 605
2022-01-07 2022-01-05 4 Lachey Jennifer KROS Common Stock S - Sale D 60,0000 −2 650 −159 85 700
2022-01-07 2022-01-05 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 2 650 1 88 350
2022-01-05 2022-01-05 4 Knowles Julius KROS Common Stock S - Sale I 59,0000 −435 −26 232 727
2022-01-05 2022-01-05 4 Knowles Julius KROS Common Stock S - Sale I 59,0000 −667 −39 341 574
2022-01-05 2022-01-05 4 Knowles Julius KROS Common Stock S - Sale I 58,2000 −886 −52 233 162
2022-01-05 2022-01-05 4 Knowles Julius KROS Common Stock S - Sale I 58,2000 −1 356 −79 342 241
2022-01-05 2022-01-05 4 Knowles Julius KROS Common Stock S - Sale I 57,2300 −271 −16 234 048
2022-01-05 2022-01-05 4 Knowles Julius KROS Common Stock S - Sale I 57,2300 −419 −24 343 597
2022-01-05 2022-01-04 4 Knowles Julius KROS Common Stock S - Sale I 58,8600 −2 195 −129 234 319
2022-01-05 2022-01-04 4 Knowles Julius KROS Common Stock S - Sale I 58,8600 −3 367 −198 344 016
2022-01-05 2022-01-04 4 Knowles Julius KROS Common Stock S - Sale I 57,9900 −2 704 −157 236 514
2022-01-05 2022-01-04 4 Knowles Julius KROS Common Stock S - Sale I 57,9900 −4 151 −241 347 383
2022-01-05 2022-01-04 4 Knowles Julius KROS Common Stock S - Sale I 56,9500 −1 113 −63 239 218
2022-01-05 2022-01-04 4 Knowles Julius KROS Common Stock S - Sale I 56,9500 −1 707 −97 351 534
2022-01-05 2022-01-04 4 Knowles Julius KROS Common Stock S - Sale I 56,1000 −1 383 −78 240 331
2022-01-05 2022-01-04 4 Knowles Julius KROS Common Stock S - Sale I 56,1000 −2 124 −119 353 241
2022-01-05 2022-01-04 4 Knowles Julius KROS Common Stock S - Sale I 54,9500 −524 −29 241 714
2022-01-05 2022-01-04 4 Knowles Julius KROS Common Stock S - Sale I 54,9500 −794 −44 355 365
2022-01-05 2022-01-03 4 Knowles Julius KROS Common Stock S - Sale I 59,4000 −162 −10 242 238
2022-01-05 2022-01-03 4 Knowles Julius KROS Common Stock S - Sale I 59,4000 −249 −15 356 159
2022-01-05 2022-01-03 4 Knowles Julius KROS Common Stock S - Sale I 58,9600 −3 412 −201 242 400
2022-01-05 2022-01-03 4 Knowles Julius KROS Common Stock S - Sale I 58,9600 −5 236 −309 356 408
2022-01-05 2022-01-03 4 Knowles Julius KROS Common Stock S - Sale I 57,8300 −3 318 −192 245 812
2022-01-05 2022-01-03 4 Knowles Julius KROS Common Stock S - Sale I 57,8300 −5 094 −295 361 644
2022-01-05 2022-01-03 4 Knowles Julius KROS Common Stock S - Sale I 56,8200 −2 406 −137 249 130
2022-01-05 2022-01-03 4 Knowles Julius KROS Common Stock S - Sale I 56,8200 −3 678 −209 366 738
2021-12-15 2021-12-15 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −735 95 255
2021-12-15 2021-12-15 4 Lachey Jennifer KROS Common Stock S - Sale D 50,0000 −735 −37 85 700
2021-12-15 2021-12-15 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 735 0 86 435
2021-12-15 2021-12-13 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −1 915 95 990
2021-12-15 2021-12-13 4 Lachey Jennifer KROS Common Stock S - Sale D 53,6400 −7 −0 85 700
2021-12-15 2021-12-13 4 Lachey Jennifer KROS Common Stock S - Sale D 52,2200 −390 −20 85 707
2021-12-15 2021-12-13 4 Lachey Jennifer KROS Common Stock S - Sale D 50,1100 −1 518 −76 86 097
2021-12-15 2021-12-13 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 1 915 1 87 615
2021-12-03 2021-12-02 4 Knowles Julius KROS Common Stock S - Sale I 54,6700 −90 −5 251 536
2021-12-03 2021-12-02 4 Knowles Julius KROS Common Stock S - Sale I 54,6700 −138 −8 370 416
2021-12-03 2021-12-02 4 Knowles Julius KROS Common Stock S - Sale I 53,8600 −5 705 −307 251 626
2021-12-03 2021-12-02 4 Knowles Julius KROS Common Stock S - Sale I 53,8600 −8 747 −471 370 554
2021-12-03 2021-12-02 4 Knowles Julius KROS Common Stock S - Sale I 53,1700 −4 155 −221 257 331
2021-12-03 2021-12-02 4 Knowles Julius KROS Common Stock S - Sale I 53,1700 −6 372 −339 379 301
2021-12-03 2021-12-02 4 Knowles Julius KROS Common Stock S - Sale I 52,0000 −52 −3 261 486
2021-12-03 2021-12-02 4 Knowles Julius KROS Common Stock S - Sale I 51,9900 −79 −4 385 673
2021-12-03 2021-12-01 4 Knowles Julius KROS Common Stock S - Sale I 56,2700 −1 021 −57 261 538
2021-12-03 2021-12-01 4 Knowles Julius KROS Common Stock S - Sale I 56,2700 −1 566 −88 385 752
2021-12-03 2021-12-01 4 Knowles Julius KROS Common Stock S - Sale I 55,7100 −1 649 −92 262 559
2021-12-03 2021-12-01 4 Knowles Julius KROS Common Stock S - Sale I 55,7100 −2 528 −141 387 318
2021-12-03 2021-12-01 4 Knowles Julius KROS Common Stock S - Sale I 54,6700 −3 372 −184 264 208
2021-12-03 2021-12-01 4 Knowles Julius KROS Common Stock S - Sale I 54,6700 −5 168 −283 389 846
2021-12-03 2021-12-01 4 Knowles Julius KROS Common Stock S - Sale I 53,4800 −2 766 −148 267 580
2021-12-03 2021-12-01 4 Knowles Julius KROS Common Stock S - Sale I 53,4800 −4 243 −227 395 014
2021-11-12 2021-11-11 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −5 300 97 905
2021-11-12 2021-11-11 4 Lachey Jennifer KROS Common Stock S - Sale D 59,7800 −4 561 −273 85 700
2021-11-12 2021-11-11 4 Lachey Jennifer KROS Common Stock S - Sale D 58,7300 −739 −43 90 261
2021-11-12 2021-11-11 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 5 300 2 91 000
2021-11-12 2021-11-10 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −15 900 103 205
2021-11-12 2021-11-10 4 Lachey Jennifer KROS Common Stock S - Sale D 60,0000 −15 900 −954 85 700
2021-11-12 2021-11-10 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 15 900 5 101 600
2021-11-05 2021-11-04 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −10 600 119 105
2021-11-05 2021-11-04 4 Lachey Jennifer KROS Common Stock S - Sale D 50,0000 −10 600 −530 85 700
2021-11-05 2021-11-04 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 10 600 3 96 300
2021-11-03 2021-11-03 4 Knowles Julius KROS Common Stock S - Sale I 42,4500 −2 346 −100 270 346
2021-11-03 2021-11-03 4 Knowles Julius KROS Common Stock S - Sale I 42,4500 −3 597 −153 399 257
2021-11-03 2021-11-03 4 Knowles Julius KROS Common Stock S - Sale I 41,6500 −3 957 −165 272 692
2021-11-03 2021-11-03 4 Knowles Julius KROS Common Stock S - Sale I 41,6500 −6 067 −253 402 854
2021-11-03 2021-11-02 4 Knowles Julius KROS Common Stock S - Sale I 43,0400 −991 −43 276 649
2021-11-03 2021-11-02 4 Knowles Julius KROS Common Stock S - Sale I 43,0400 −1 518 −65 408 921
2021-11-03 2021-11-02 4 Knowles Julius KROS Common Stock S - Sale I 42,1000 −2 120 −89 277 640
2021-11-03 2021-11-02 4 Knowles Julius KROS Common Stock S - Sale I 42,1000 −3 252 −137 410 439
2021-11-03 2021-11-01 4 Knowles Julius KROS Common Stock S - Sale I 42,4300 −4 797 −204 279 760
2021-11-03 2021-11-01 4 Knowles Julius KROS Common Stock S - Sale I 42,4300 −7 350 −312 413 691
2021-11-03 2021-11-01 4 Knowles Julius KROS Common Stock S - Sale I 41,8500 −4 599 −192 284 557
2021-11-03 2021-11-01 4 Knowles Julius KROS Common Stock S - Sale I 41,8500 −7 057 −295 421 041
2021-10-21 2021-10-20 4 Knowles Julius KROS Common Stock S - Sale I 38,3100 −1 463 −56 289 156
2021-10-21 2021-10-20 4 Knowles Julius KROS Common Stock S - Sale I 38,3100 −2 242 −86 428 098
2021-10-21 2021-10-20 4 Knowles Julius KROS Common Stock S - Sale I 37,5500 −148 −6 290 619
2021-10-21 2021-10-20 4 Knowles Julius KROS Common Stock S - Sale I 37,5500 −229 −9 430 340
2021-10-21 2021-10-19 4 Knowles Julius KROS Common Stock S - Sale I 38,4900 −460 −18 290 767
2021-10-21 2021-10-19 4 Knowles Julius KROS Common Stock S - Sale I 38,4900 −704 −27 430 569
2021-10-21 2021-10-19 4 Knowles Julius KROS Common Stock S - Sale I 38,0500 −1 323 −50 291 227
2021-10-21 2021-10-19 4 Knowles Julius KROS Common Stock S - Sale I 38,0500 −2 029 −77 431 273
2021-10-18 2021-10-18 4 Knowles Julius KROS Common Stock S - Sale I 38,4600 −60 −2 292 550
2021-10-18 2021-10-18 4 Knowles Julius KROS Common Stock S - Sale I 38,4600 −92 −4 433 302
2021-10-18 2021-10-18 4 Knowles Julius KROS Common Stock S - Sale I 37,6900 −5 382 −203 292 610
2021-10-18 2021-10-18 4 Knowles Julius KROS Common Stock S - Sale I 37,6900 −8 252 −311 433 394
2021-10-18 2021-10-15 4 Knowles Julius KROS Common Stock S - Sale I 40,6000 −60 −2 297 992
2021-10-18 2021-10-15 4 Knowles Julius KROS Common Stock S - Sale I 40,6000 −92 −4 441 646
2021-10-18 2021-10-15 4 Knowles Julius KROS Common Stock S - Sale I 39,4400 −1 199 −47 298 052
2021-10-18 2021-10-15 4 Knowles Julius KROS Common Stock S - Sale I 39,4400 −1 839 −73 441 738
2021-10-18 2021-10-15 4 Knowles Julius KROS Common Stock S - Sale I 38,9500 −1 977 −77 299 251
2021-10-18 2021-10-15 4 Knowles Julius KROS Common Stock S - Sale I 38,9500 −3 031 −118 443 577
2021-10-18 2021-10-14 4 Knowles Julius KROS Common Stock S - Sale I 40,1300 −1 730 −69 301 228
2021-10-18 2021-10-14 4 Knowles Julius KROS Common Stock S - Sale I 40,1300 −2 653 −106 446 608
2021-10-05 2021-10-05 4 Knowles Julius KROS Common Stock S - Sale I 40,0300 −1 033 −41 302 958
2021-10-05 2021-10-05 4 Knowles Julius KROS Common Stock S - Sale I 40,0300 −1 584 −63 449 261
2021-10-05 2021-10-04 4 Knowles Julius KROS Common Stock S - Sale I 40,0600 −1 479 −59 303 991
2021-10-05 2021-10-04 4 Knowles Julius KROS Common Stock S - Sale I 40,0600 −2 267 −91 450 845
2021-10-05 2021-10-01 4 Knowles Julius KROS Common Stock S - Sale I 40,1600 −2 496 −100 305 470
2021-10-05 2021-10-01 4 Knowles Julius KROS Common Stock S - Sale I 40,1600 −3 827 −154 453 112
2021-09-29 2021-09-27 4 Knowles Julius KROS Common Stock S - Sale I 42,2900 −6 532 −276 307 966
2021-09-29 2021-09-27 4 Knowles Julius KROS Common Stock S - Sale I 42,2900 −10 018 −424 456 939
2021-09-29 2021-09-27 4 Knowles Julius KROS Common Stock S - Sale I 41,5200 −13 233 −549 314 498
2021-09-29 2021-09-27 4 Knowles Julius KROS Common Stock S - Sale I 41,5200 −20 292 −843 466 957
2021-09-29 2021-09-27 4 Knowles Julius KROS Common Stock S - Sale I 40,5100 −17 854 −723 327 731
2021-09-29 2021-09-27 4 Knowles Julius KROS Common Stock S - Sale I 40,5100 −27 373 −1 109 487 249
2021-08-18 2021-08-17 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −1 293 0
2021-08-18 2021-08-17 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 1 293 0 85 700
2021-08-11 2021-08-10 4 Cooper Simon Peter KROS Employee Stock Option (right to buy) A - Award D 34,98 60 000 60 000
2021-07-06 2021-07-02 4 Knowles Julius KROS Common Stock S - Sale I 41,7200 −3 776 −158 345 585
2021-07-06 2021-07-02 4 Knowles Julius KROS Common Stock S - Sale I 41,7200 −5 789 −242 514 622
2021-07-06 2021-07-02 4 Knowles Julius KROS Common Stock S - Sale I 41,0800 −5 626 −231 349 361
2021-07-06 2021-07-02 4 Knowles Julius KROS Common Stock S - Sale I 41,0800 −8 627 −354 520 411
2021-07-06 2021-07-01 4 Knowles Julius KROS Common Stock S - Sale I 42,7500 −30 −1 354 987
2021-07-06 2021-07-01 4 Knowles Julius KROS Common Stock S - Sale I 42,7500 −46 −2 529 038
2021-07-06 2021-07-01 4 Knowles Julius KROS Common Stock S - Sale I 41,8900 −728 −30 355 017
2021-07-06 2021-07-01 4 Knowles Julius KROS Common Stock S - Sale I 41,8900 −1 112 −47 529 084
2021-07-06 2021-07-01 4 Knowles Julius KROS Common Stock S - Sale I 41,2200 −8 650 −357 355 745
2021-07-06 2021-07-01 4 Knowles Julius KROS Common Stock S - Sale I 41,2200 −13 268 −547 530 196
2021-06-25 2021-06-24 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −6 500 1 293
2021-06-25 2021-06-24 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 6 500 2 84 407
2021-06-15 2021-06-11 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −2 650 129 705
2021-06-15 2021-06-11 4 Lachey Jennifer KROS Common Stock S - Sale D 52,1300 −219 −11 77 907
2021-06-15 2021-06-11 4 Lachey Jennifer KROS Common Stock S - Sale D 51,7300 −898 −46 78 126
2021-06-15 2021-06-11 4 Lachey Jennifer KROS Common Stock S - Sale D 50,3700 −1 533 −77 79 024
2021-06-15 2021-06-11 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 2 650 1 80 557
2021-06-15 2021-06-11 4 Ordonez Claudia KROS Employee Stock Option (right to buy) M - Exercise D 0,48 −1 000 98 211
2021-06-15 2021-06-11 4 Ordonez Claudia KROS Common Stock S - Sale D 51,9500 −347 −18 0
2021-06-15 2021-06-11 4 Ordonez Claudia KROS Common Stock S - Sale D 50,4800 −653 −33 347
2021-06-15 2021-06-11 4 Ordonez Claudia KROS Common Stock M - Exercise D 0,4800 1 000 0 1 000
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 51,4600 −560 −29 364 395
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 51,4600 −858 −44 543 464
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 50,8000 −2 586 −131 364 955
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 50,8000 −3 968 −202 544 322
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 50,0200 −568 −28 367 541
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 50,0200 −870 −44 548 290
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 48,7600 −366 −18 368 109
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 48,7600 −560 −27 549 160
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 47,3400 −512 −24 368 475
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 47,3400 −786 −37 549 720
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 46,4800 −459 −21 368 987
2021-06-08 2021-06-07 4 Knowles Julius KROS Common Stock S - Sale I 46,4800 −703 −33 550 506
2021-06-08 2021-06-04 4 Knowles Julius KROS Common Stock S - Sale I 48,1500 −663 −32 369 446
2021-06-08 2021-06-04 4 Knowles Julius KROS Common Stock S - Sale I 48,1500 −1 018 −49 551 209
2021-06-08 2021-06-04 4 Knowles Julius KROS Common Stock S - Sale I 47,2300 −1 950 −92 370 109
2021-06-08 2021-06-04 4 Knowles Julius KROS Common Stock S - Sale I 47,2300 −2 988 −141 552 227
2021-06-03 2021-06-03 4 Knowles Julius KROS Common Stock S - Sale I 48,1500 −1 903 −92 372 059
2021-06-03 2021-06-03 4 Knowles Julius KROS Common Stock S - Sale I 48,1500 −2 917 −140 555 215
2021-06-03 2021-06-03 4 Knowles Julius KROS Common Stock S - Sale I 47,6900 −1 213 −58 373 962
2021-06-03 2021-06-03 4 Knowles Julius KROS Common Stock S - Sale I 47,6900 −1 862 −89 558 132
2021-06-03 2021-06-02 4 Knowles Julius KROS Common Stock S - Sale I 51,4500 −91 −5 375 175
2021-06-03 2021-06-02 4 Knowles Julius KROS Common Stock S - Sale I 51,4500 −138 −7 559 994
2021-06-03 2021-06-02 4 Knowles Julius KROS Common Stock S - Sale I 50,5200 −361 −18 375 266
2021-06-03 2021-06-02 4 Knowles Julius KROS Common Stock S - Sale I 50,5200 −553 −28 560 132
2021-06-03 2021-06-02 4 Knowles Julius KROS Common Stock S - Sale I 49,2600 −874 −43 375 627
2021-06-03 2021-06-02 4 Knowles Julius KROS Common Stock S - Sale I 49,2600 −1 343 −66 560 685
2021-06-03 2021-06-02 4 Knowles Julius KROS Common Stock S - Sale I 48,3500 −3 225 −156 376 501
2021-06-03 2021-06-02 4 Knowles Julius KROS Common Stock S - Sale I 48,3500 −4 944 −239 562 028
2021-06-03 2021-06-01 4 Knowles Julius KROS Common Stock S - Sale I 54,6200 −30 −2 379 726
2021-06-03 2021-06-01 4 Knowles Julius KROS Common Stock S - Sale I 54,6200 −46 −3 566 972
2021-06-03 2021-06-01 4 Knowles Julius KROS Common Stock S - Sale I 53,7700 −414 −22 379 756
2021-06-03 2021-06-01 4 Knowles Julius KROS Common Stock S - Sale I 53,7700 −633 −34 567 018
2021-06-03 2021-06-01 4 Knowles Julius KROS Common Stock S - Sale I 52,7200 −1 531 −81 380 170
2021-06-03 2021-06-01 4 Knowles Julius KROS Common Stock S - Sale I 52,7200 −2 345 −124 567 651
2021-06-03 2021-06-01 4 Knowles Julius KROS Common Stock S - Sale I 51,9000 −1 504 −78 381 701
2021-06-03 2021-06-01 4 Knowles Julius KROS Common Stock S - Sale I 51,9000 −2 309 −120 569 996
2021-06-03 2021-06-01 4 Nussbaum Ran KROS Stock Option (right to buy) A - Award D 51,48 8 293 8 293
2021-06-03 2021-06-01 4 Knowles Julius KROS Stock Option (right to buy) A - Award D 51,48 8 293 8 293
2021-06-03 2021-06-01 4 Kariv Tomer KROS Stock Option (right to buy) A - Award D 51,48 8 293 8 293
2021-06-03 2021-06-01 4 GRAY MARY ANN KROS Stock Option (right to buy) A - Award D 51,48 8 293 8 293
2021-06-03 2021-06-01 4 Farzan Nima KROS Stock Option (right to buy) A - Award D 51,48 8 293 8 293
2021-06-03 2021-06-01 4 GORDON CARL L KROS Stock Option (right to buy) A - Award D 51,48 8 293 8 293
2021-05-13 2021-05-13 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −500 7 793
2021-05-13 2021-05-13 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,11 −6 220 0
2021-05-13 2021-05-13 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 500 0 77 907
2021-05-13 2021-05-13 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,1100 6 220 1 77 407
2021-05-13 2021-05-11 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −2 650 132 355
2021-05-13 2021-05-11 4 Lachey Jennifer KROS Common Stock S - Sale D 50,0000 −2 650 −132 71 187
2021-05-13 2021-05-11 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 2 650 1 73 837
2021-05-13 2021-05-11 4 Ordonez Claudia KROS Employee Stock Option (right to buy) M - Exercise D 0,48 −1 000 99 211
2021-05-13 2021-05-11 4 Ordonez Claudia KROS Common Stock S - Sale D 50,1500 −1 000 −50 0
2021-05-13 2021-05-11 4 Ordonez Claudia KROS Common Stock M - Exercise D 0,4800 1 000 0 1 000
2021-05-05 2021-05-04 4 Knowles Julius KROS Common Stock S - Sale I 54,3500 −339 −18 383 205
2021-05-05 2021-05-04 4 Knowles Julius KROS Common Stock S - Sale I 54,3500 −520 −28 572 305
2021-05-05 2021-05-04 4 Knowles Julius KROS Common Stock S - Sale I 53,7300 −780 −42 383 544
2021-05-05 2021-05-04 4 Knowles Julius KROS Common Stock S - Sale I 53,7300 −1 196 −64 572 825
2021-05-05 2021-05-03 4 Knowles Julius KROS Common Stock S - Sale I 59,4800 −616 −37 384 324
2021-05-05 2021-05-03 4 Knowles Julius KROS Common Stock S - Sale I 59,4800 −942 −56 574 021
2021-05-05 2021-05-03 4 Knowles Julius KROS Common Stock S - Sale I 58,7800 −4 506 −265 384 940
2021-05-05 2021-05-03 4 Knowles Julius KROS Common Stock S - Sale I 58,7800 −6 905 −406 574 963
2021-05-05 2021-05-03 4 Knowles Julius KROS Common Stock S - Sale I 57,8600 −4 600 −266 389 446
2021-05-05 2021-05-03 4 Knowles Julius KROS Common Stock S - Sale I 57,8600 −7 054 −408 581 868
2021-05-05 2021-05-03 4 Knowles Julius KROS Common Stock S - Sale I 56,6300 −4 460 −253 394 046
2021-05-05 2021-05-03 4 Knowles Julius KROS Common Stock S - Sale I 56,6300 −6 841 −387 588 922
2021-05-05 2021-05-03 4 Knowles Julius KROS Common Stock S - Sale I 56,0400 −3 509 −197 398 506
2021-05-05 2021-05-03 4 Knowles Julius KROS Common Stock S - Sale I 56,0400 −5 383 −302 595 763
2021-04-14 2021-04-12 4 Ordonez Claudia KROS Employee Stock Option (right to buy) M - Exercise D 0,48 −1 000 100 211
2021-04-14 2021-04-12 4 Ordonez Claudia KROS Common Stock S - Sale D 61,2300 −233 −14 0
2021-04-14 2021-04-12 4 Ordonez Claudia KROS Common Stock S - Sale D 60,0100 −367 −22 233
2021-04-14 2021-04-12 4 Ordonez Claudia KROS Common Stock S - Sale D 59,0900 −400 −24 600
2021-04-14 2021-04-12 4 Ordonez Claudia KROS Common Stock M - Exercise D 0,4800 1 000 0 1 000
2021-04-14 2021-04-12 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −5 300 135 005
2021-04-14 2021-04-12 4 Lachey Jennifer KROS Common Stock S - Sale D 61,7200 −100 −6 71 187
2021-04-14 2021-04-12 4 Lachey Jennifer KROS Common Stock S - Sale D 61,0800 −729 −45 71 287
2021-04-14 2021-04-12 4 Lachey Jennifer KROS Common Stock S - Sale D 59,9900 −3 473 −208 72 016
2021-04-14 2021-04-12 4 Lachey Jennifer KROS Common Stock S - Sale D 59,1000 −998 −59 75 489
2021-04-14 2021-04-12 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 5 300 2 76 487
2021-04-08 2021-04-06 4 Knowles Julius KROS Common Stock S - Sale I 59,9500 −35 −2 402 015
2021-04-08 2021-04-06 4 Knowles Julius KROS Common Stock S - Sale I 59,9500 −54 −3 601 146
2021-04-08 2021-04-06 4 Knowles Julius KROS Common Stock S - Sale I 59,1000 −2 402 −142 402 050
2021-04-08 2021-04-06 4 Knowles Julius KROS Common Stock S - Sale I 59,1000 −3 685 −218 601 200
2021-04-08 2021-04-06 4 Knowles Julius KROS Common Stock S - Sale I 58,2200 −1 233 −72 404 452
2021-04-08 2021-04-06 4 Knowles Julius KROS Common Stock S - Sale I 58,2200 −1 889 −110 604 885
2021-04-05 2021-04-05 4 Knowles Julius KROS Common Stock S - Sale I 60,2600 −6 972 −420 405 685
2021-04-05 2021-04-05 4 Knowles Julius KROS Common Stock S - Sale I 60,2600 −10 690 −644 606 774
2021-04-05 2021-04-05 4 Knowles Julius KROS Common Stock S - Sale I 59,7600 −3 551 −212 412 657
2021-04-05 2021-04-05 4 Knowles Julius KROS Common Stock S - Sale I 59,7600 −5 445 −325 617 464
2021-04-05 2021-04-05 4 Knowles Julius KROS Common Stock S - Sale I 58,6600 −195 −11 416 208
2021-04-05 2021-04-05 4 Knowles Julius KROS Common Stock S - Sale I 58,6600 −298 −17 622 909
2021-04-05 2021-04-01 4 Knowles Julius KROS Common Stock S - Sale I 61,3600 −134 −8 416 403
2021-04-05 2021-04-01 4 Knowles Julius KROS Common Stock S - Sale I 61,3600 −206 −13 623 207
2021-04-05 2021-04-01 4 Knowles Julius KROS Common Stock S - Sale I 60,8200 −283 −17 416 537
2021-04-05 2021-04-01 4 Knowles Julius KROS Common Stock S - Sale I 60,8200 −434 −26 623 413
2021-04-05 2021-04-01 4 Knowles Julius KROS Common Stock S - Sale I 59,0800 −1 533 −91 416 820
2021-04-05 2021-04-01 4 Knowles Julius KROS Common Stock S - Sale I 59,0800 −2 350 −139 623 847
2021-04-05 2021-04-01 4 Knowles Julius KROS Common Stock S - Sale I 58,4200 −2 472 −144 418 353
2021-04-05 2021-04-01 4 Knowles Julius KROS Common Stock S - Sale I 58,4200 −3 790 −221 626 197
2021-04-02 2021-04-01 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,11 −9 996 0
2021-04-02 2021-04-01 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,1100 9 996 1 71 187
2021-03-15 2021-03-11 4 Ordonez Claudia KROS Employee Stock Option (right to buy) M - Exercise D 0,48 −1 000 101 211
2021-03-15 2021-03-11 4 Ordonez Claudia KROS Common Stock S - Sale D 64,8600 −605 −39 0
2021-03-15 2021-03-11 4 Ordonez Claudia KROS Common Stock S - Sale D 64,0900 −395 −25 605
2021-03-15 2021-03-11 4 Ordonez Claudia KROS Common Stock M - Exercise D 0,4800 1 000 0 1 000
2021-03-15 2021-03-11 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −5 300 140 305
2021-03-15 2021-03-11 4 Lachey Jennifer KROS Common Stock S - Sale D 65,4700 −4 −0 61 191
2021-03-15 2021-03-11 4 Lachey Jennifer KROS Common Stock S - Sale D 64,7200 −3 557 −230 61 195
2021-03-15 2021-03-11 4 Lachey Jennifer KROS Common Stock S - Sale D 63,9900 −1 739 −111 64 752
2021-03-15 2021-03-11 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 5 300 2 66 491
2021-03-05 2021-03-04 4 Knowles Julius KROS Common Stock S - Sale I 58,0300 −126 −7 420 825
2021-03-05 2021-03-04 4 Knowles Julius KROS Common Stock S - Sale I 58,0300 −193 −11 629 987
2021-03-05 2021-03-04 4 Knowles Julius KROS Common Stock S - Sale I 57,2100 −553 −32 420 951
2021-03-05 2021-03-04 4 Knowles Julius KROS Common Stock S - Sale I 57,2100 −847 −48 630 180
2021-03-05 2021-03-04 4 Knowles Julius KROS Common Stock S - Sale I 56,1800 −895 −50 421 504
2021-03-05 2021-03-04 4 Knowles Julius KROS Common Stock S - Sale I 56,1800 −1 376 −77 631 027
2021-03-05 2021-03-04 4 Knowles Julius KROS Common Stock S - Sale I 55,2100 −1 932 −107 422 399
2021-03-05 2021-03-04 4 Knowles Julius KROS Common Stock S - Sale I 55,2100 −2 962 −164 632 403
2021-03-05 2021-03-04 4 Knowles Julius KROS Common Stock S - Sale I 54,2200 −1 086 −59 424 331
2021-03-05 2021-03-04 4 Knowles Julius KROS Common Stock S - Sale I 54,2200 −1 662 −90 635 365
2021-03-05 2021-03-03 4 Knowles Julius KROS Common Stock S - Sale I 58,8800 −496 −29 425 417
2021-03-05 2021-03-03 4 Knowles Julius KROS Common Stock S - Sale I 58,8800 −761 −45 637 027
2021-03-05 2021-03-03 4 Knowles Julius KROS Common Stock S - Sale I 57,7900 −1 894 −109 425 913
2021-03-05 2021-03-03 4 Knowles Julius KROS Common Stock S - Sale I 57,7900 −2 903 −168 637 788
2021-03-05 2021-03-03 4 Knowles Julius KROS Common Stock S - Sale I 56,9500 −1 958 −112 427 807
2021-03-05 2021-03-03 4 Knowles Julius KROS Common Stock S - Sale I 56,9500 −3 004 −171 640 691
2021-03-05 2021-03-03 4 Knowles Julius KROS Common Stock S - Sale I 55,9100 −518 −29 429 765
2021-03-05 2021-03-03 4 Knowles Julius KROS Common Stock S - Sale I 55,9100 −793 −44 643 695
2021-03-03 2021-03-02 4 Knowles Julius KROS Common Stock S - Sale I 61,9000 −90 −6 430 283
2021-03-03 2021-03-02 4 Knowles Julius KROS Common Stock S - Sale I 61,9000 −138 −9 644 488
2021-03-03 2021-03-02 4 Knowles Julius KROS Common Stock S - Sale I 60,6100 −361 −22 430 373
2021-03-03 2021-03-02 4 Knowles Julius KROS Common Stock S - Sale I 60,6100 −554 −34 644 626
2021-03-03 2021-03-02 4 Knowles Julius KROS Common Stock S - Sale I 60,0500 −686 −41 430 734
2021-03-03 2021-03-02 4 Knowles Julius KROS Common Stock S - Sale I 60,0500 −1 052 −63 645 180
2021-03-03 2021-03-02 4 Knowles Julius KROS Common Stock S - Sale I 58,9000 −714 −42 431 420
2021-03-03 2021-03-02 4 Knowles Julius KROS Common Stock S - Sale I 58,9000 −1 095 −64 646 232
2021-03-03 2021-03-02 4 Knowles Julius KROS Common Stock S - Sale I 57,9300 −2 377 −138 432 134
2021-03-03 2021-03-02 4 Knowles Julius KROS Common Stock S - Sale I 57,9300 −3 644 −211 647 327
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 67,6000 −30 −2 434 511
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 67,6000 −46 −3 650 971
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 66,0400 −516 −34 434 541
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 66,0400 −792 −52 651 017
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 65,2800 −479 −31 435 057
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 65,2900 −734 −48 651 809
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 64,0900 −406 −26 435 536
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 64,0900 −625 −40 652 543
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 63,2200 −1 169 −74 435 942
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 63,2200 −1 794 −113 653 168
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 62,1100 −1 473 −91 437 111
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 62,1100 −2 257 −140 654 962
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 61,3300 −1 050 −64 438 584
2021-03-03 2021-03-01 4 Knowles Julius KROS Common Stock S - Sale I 61,3300 −1 608 −99 657 219
2021-03-01 2021-02-26 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,11 −33 200 9 996
2021-03-01 2021-02-26 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,1100 33 200 4 61 191
2021-02-18 2021-02-18 4 Knowles Julius KROS Common Stock S - Sale I 65,0100 −75 −5 439 634
2021-02-18 2021-02-18 4 Knowles Julius KROS Common Stock S - Sale I 65,0200 −116 −8 658 827
2021-02-18 2021-02-18 4 Knowles Julius KROS Common Stock S - Sale I 64,1700 −552 −35 439 709
2021-02-18 2021-02-18 4 Knowles Julius KROS Common Stock S - Sale I 64,1600 −845 −54 658 943
2021-02-18 2021-02-18 4 Knowles Julius KROS Common Stock S - Sale I 63,0400 −205 −13 440 261
2021-02-18 2021-02-18 4 Knowles Julius KROS Common Stock S - Sale I 63,0400 −315 −20 659 788
2021-02-18 2021-02-18 4 Knowles Julius KROS Common Stock S - Sale I 61,6800 −180 −11 440 466
2021-02-18 2021-02-18 4 Knowles Julius KROS Common Stock S - Sale I 61,6800 −276 −17 660 103
2021-02-18 2021-02-18 4 Knowles Julius KROS Common Stock S - Sale I 60,0600 −150 −9 440 646
2021-02-18 2021-02-18 4 Knowles Julius KROS Common Stock S - Sale I 60,0600 −230 −14 660 379
2021-02-18 2021-02-17 4 Knowles Julius KROS Common Stock S - Sale I 62,7200 −1 705 −107 440 796
2021-02-18 2021-02-17 4 Knowles Julius KROS Common Stock S - Sale I 62,7200 −2 613 −164 660 609
2021-02-18 2021-02-17 4 Knowles Julius KROS Common Stock S - Sale I 61,8000 −1 201 −74 442 501
2021-02-18 2021-02-17 4 Knowles Julius KROS Common Stock S - Sale I 61,8000 −1 841 −114 663 222
2021-02-18 2021-02-17 4 Knowles Julius KROS Common Stock S - Sale I 60,6600 −764 −46 443 702
2021-02-18 2021-02-17 4 Knowles Julius KROS Common Stock S - Sale I 60,6600 −1 173 −71 665 063
2021-02-18 2021-02-17 4 Knowles Julius KROS Common Stock S - Sale I 59,9600 −2 249 −135 444 466
2021-02-18 2021-02-17 4 Knowles Julius KROS Common Stock S - Sale I 59,9600 −3 449 −207 666 236
2021-02-18 2021-02-17 4 Knowles Julius KROS Common Stock S - Sale I 58,7400 −421 −25 446 715
2021-02-18 2021-02-17 4 Knowles Julius KROS Common Stock S - Sale I 58,7400 −645 −38 669 685
2021-02-18 2021-02-16 4 Knowles Julius KROS Common Stock S - Sale I 60,9200 −90 −5 447 136
2021-02-18 2021-02-16 4 Knowles Julius KROS Common Stock S - Sale I 60,9200 −138 −8 670 330
2021-02-18 2021-02-16 4 Knowles Julius KROS Common Stock S - Sale I 60,2300 −2 609 −157 447 226
2021-02-18 2021-02-16 4 Knowles Julius KROS Common Stock S - Sale I 60,2300 −3 999 −241 670 468
2021-02-18 2021-02-16 4 Knowles Julius KROS Common Stock S - Sale I 59,3400 −661 −39 449 835
2021-02-18 2021-02-16 4 Knowles Julius KROS Common Stock S - Sale I 59,3400 −1 014 −60 674 467
2021-02-18 2021-02-16 4 Knowles Julius KROS Common Stock S - Sale I 58,4800 −434 −25 450 496
2021-02-18 2021-02-16 4 Knowles Julius KROS Common Stock S - Sale I 58,4800 −667 −39 675 481
2021-02-16 2021-02-12 4 Knowles Julius KROS Common Stock S - Sale I 63,8500 −30 −2 450 930
2021-02-16 2021-02-12 4 Knowles Julius KROS Common Stock S - Sale I 63,8500 −46 −3 676 148
2021-02-16 2021-02-12 4 Knowles Julius KROS Common Stock S - Sale I 63,1400 −531 −34 450 960
2021-02-16 2021-02-12 4 Knowles Julius KROS Common Stock S - Sale I 63,1400 −814 −51 676 194
2021-02-16 2021-02-12 4 Knowles Julius KROS Common Stock S - Sale I 62,5200 −641 −40 451 491
2021-02-16 2021-02-12 4 Knowles Julius KROS Common Stock S - Sale I 62,5200 −985 −62 677 008
2021-02-16 2021-02-12 4 Knowles Julius KROS Common Stock S - Sale I 61,0300 −913 −56 452 132
2021-02-16 2021-02-12 4 Knowles Julius KROS Common Stock S - Sale I 61,0300 −1 397 −85 677 993
2021-02-16 2021-02-12 4 Knowles Julius KROS Common Stock S - Sale I 60,2000 −833 −50 453 045
2021-02-16 2021-02-12 4 Knowles Julius KROS Common Stock S - Sale I 60,2000 −1 278 −77 679 390
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 67,9800 −35 −2 453 878
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 67,9900 −53 −4 680 668
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 66,6500 −206 −14 453 913
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 66,6500 −316 −21 680 721
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 65,8000 −1 575 −104 454 119
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 65,8000 −2 418 −159 681 037
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 64,8700 −952 −62 455 694
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 64,8700 −1 461 −95 683 455
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 63,8300 −1 526 −97 456 646
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 63,8300 −2 335 −149 684 916
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 62,7900 −270 −17 458 172
2021-02-16 2021-02-11 4 Knowles Julius KROS Common Stock S - Sale I 62,7900 −414 −26 687 251
2021-02-16 2021-02-11 4 Ordonez Claudia KROS Employee Stock Option (right to buy) M - Exercise D 0,48 −1 000 102 211
2021-02-16 2021-02-11 4 Ordonez Claudia KROS Common Stock S - Sale D 68,0500 −2 −0 0
2021-02-16 2021-02-11 4 Ordonez Claudia KROS Common Stock S - Sale D 66,1900 −295 −20 2
2021-02-16 2021-02-11 4 Ordonez Claudia KROS Common Stock S - Sale D 65,3500 −216 −14 297
2021-02-16 2021-02-11 4 Ordonez Claudia KROS Common Stock S - Sale D 64,1700 −312 −20 513
2021-02-16 2021-02-11 4 Ordonez Claudia KROS Common Stock S - Sale D 63,1000 −175 −11 825
2021-02-16 2021-02-11 4 Ordonez Claudia KROS Common Stock M - Exercise D 0,4800 1 000 0 1 000
2021-02-16 2021-02-11 4 Lachey Jennifer KROS Employee Stock Option (right to buy) M - Exercise D 0,30 −5 300 145 605
2021-02-16 2021-02-11 4 Lachey Jennifer KROS Common Stock S - Sale D 68,0500 −14 −1 27 991
2021-02-16 2021-02-11 4 Lachey Jennifer KROS Common Stock S - Sale D 67,0500 −262 −18 28 005
2021-02-16 2021-02-11 4 Lachey Jennifer KROS Common Stock S - Sale D 65,9900 −1 845 −122 28 267
2021-02-16 2021-02-11 4 Lachey Jennifer KROS Common Stock S - Sale D 64,9300 −1 272 −83 30 112
2021-02-16 2021-02-11 4 Lachey Jennifer KROS Common Stock S - Sale D 63,7400 −1 460 −93 31 384
2021-02-16 2021-02-11 4 Lachey Jennifer KROS Common Stock S - Sale D 62,8500 −447 −28 32 844
2021-02-16 2021-02-11 4 Lachey Jennifer KROS Common Stock M - Exercise D 0,3000 5 300 2 33 291
2021-01-12 2021-01-10 4 Regnante Keith KROS Employee Stock Option (right to buy) A - Award D 70,93 49 150 49 150
2021-01-12 2021-01-10 4 Ordonez Claudia KROS Employee Stock Option (right to buy) A - Award D 70,93 42 250 42 250
2021-01-12 2021-01-10 4 Lachey Jennifer KROS Employee Stock Option (right to buy) A - Award D 70,93 42 250 42 250
2021-01-12 2021-01-10 4 Seehra Jasbir KROS Employee Stock Option (right to buy) A - Award D 70,93 127 200 127 200
2020-12-21 2020-12-17 4 GRAY MARY ANN KROS Stock Option (right to buy) A - Award D 82,74 16 587 16 587
2020-11-19 2020-11-17 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock P - Purchase I 50,0000 6 000 300 155 262
2020-11-19 2020-11-17 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock P - Purchase I 50,0000 14 400 720 1 228 326
2020-11-19 2020-11-17 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock P - Purchase I 50,0000 12 966 648 1 122 768
2020-11-19 2020-11-17 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock P - Purchase I 50,0000 26 634 1 332 2 288 151
2020-11-19 2020-11-17 4 Nussbaum Ran KROS Common Stock P - Purchase I 50,0000 6 000 300 155 262
2020-11-19 2020-11-17 4 Nussbaum Ran KROS Common Stock P - Purchase I 50,0000 14 400 720 1 228 326
2020-11-19 2020-11-17 4 Nussbaum Ran KROS Common Stock P - Purchase I 50,0000 12 966 648 1 122 768
2020-11-19 2020-11-17 4 Nussbaum Ran KROS Common Stock P - Purchase I 50,0000 26 634 1 332 2 288 151
2020-11-19 2020-11-17 4 Kariv Tomer KROS Common Stock P - Purchase I 50,0000 6 000 300 155 262
2020-11-19 2020-11-17 4 Kariv Tomer KROS Common Stock P - Purchase I 50,0000 14 400 720 1 228 326
2020-11-19 2020-11-17 4 Kariv Tomer KROS Common Stock P - Purchase I 50,0000 12 966 648 1 122 768
2020-11-19 2020-11-17 4 Kariv Tomer KROS Common Stock P - Purchase I 50,0000 26 634 1 332 2 288 151
2020-05-29 2020-05-29 4 Farzan Nima KROS Stock Option (right to buy) A - Award D 28,74 8 500 8 500
2020-04-13 2020-04-13 4 Arkin Bio Ventures Limited Partnership KROS Series C Preferred Stock C - Conversion D −167 537 0
2020-04-13 2020-04-13 4 Arkin Bio Ventures Limited Partnership KROS Series B-1 Preferred Stock C - Conversion D −343 270 0
2020-04-13 2020-04-13 4 Arkin Bio Ventures Limited Partnership KROS Series A Preferred Stock C - Conversion D −1 382 295 0
2020-04-13 2020-04-13 4 Arkin Bio Ventures Limited Partnership KROS Common Stock P - Purchase D 16,0000 120 000 1 920 2 013 102
2020-04-13 2020-04-13 4 Arkin Bio Ventures Limited Partnership KROS Common Stock C - Conversion D 167 537 1 893 102
2020-04-13 2020-04-13 4 Arkin Bio Ventures Limited Partnership KROS Common Stock C - Conversion D 343 270 1 725 565
2020-04-13 2020-04-13 4 Arkin Bio Ventures Limited Partnership KROS Common Stock C - Conversion D 1 382 295 1 382 295
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Series C Preferred Stock C - Conversion I −36 858 0
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Series C Preferred Stock C - Conversion I −79 653 0
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Series C Preferred Stock C - Conversion I −88 460 0
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Series C Preferred Stock C - Conversion I −163 612 0
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Series B-1 Preferred Stock C - Conversion I −68 654 0
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Series B-1 Preferred Stock C - Conversion I −91 538 0
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Series B-1 Preferred Stock C - Conversion I −82 425 0
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Series B-1 Preferred Stock C - Conversion I −169 307 0
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Series A Preferred Stock C - Conversion I −737 226 0
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Series A Preferred Stock C - Conversion I −663 825 0
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Series A Preferred Stock C - Conversion I −1 363 542 0
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock P - Purchase I 16,0000 43 750 700 149 262
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock P - Purchase I 16,0000 105 000 1 680 1 213 926
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock P - Purchase I 16,0000 94 546 1 513 1 109 802
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock P - Purchase I 16,0000 194 203 3 107 2 261 517
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock C - Conversion I 36 858 105 512
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock C - Conversion I 79 653 1 108 926
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock C - Conversion I 88 460 1 015 256
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock C - Conversion I 163 612 2 067 314
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock C - Conversion I 68 654 68 654
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock C - Conversion I 91 538 1 029 273
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock C - Conversion I 82 425 926 796
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock C - Conversion I 169 307 1 903 702
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock C - Conversion I 737 226 937 735
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock C - Conversion I 663 825 844 371
2020-04-13 2020-04-13 4 Pontifax Management 4 G.P. (2015) Ltd. KROS Common Stock C - Conversion I 1 363 542 1 734 395
2020-04-13 2020-04-13 4 Seehra Jasbir KROS Series C Preferred Stock C - Conversion D −11 169 0
2020-04-13 2020-04-13 4 Seehra Jasbir KROS Common Stock P - Purchase D 16,0000 20 000 320 243 856
2020-04-13 2020-04-13 4 Seehra Jasbir KROS Common Stock C - Conversion D 11 169 223 856
2020-04-13 2020-04-13 4 GORDON CARL L KROS Series C Preferred Stock C - Conversion I −148 922 0
2020-04-13 2020-04-13 4 GORDON CARL L KROS Series C Preferred Stock C - Conversion I −744 612 0
2020-04-13 2020-04-13 4 GORDON CARL L KROS Common Stock P - Purchase I 16,0000 375 200 6 003 1 119 812
2020-04-13 2020-04-13 4 GORDON CARL L KROS Common Stock C - Conversion I 148 922 148 922
2020-04-13 2020-04-13 4 GORDON CARL L KROS Common Stock C - Conversion I 744 612 744 612
2020-04-13 2020-04-13 4 Kariv Tomer KROS Series C Preferred Stock C - Conversion I −36 858 0
2020-04-13 2020-04-13 4 Kariv Tomer KROS Series C Preferred Stock C - Conversion I −79 653 0
2020-04-13 2020-04-13 4 Kariv Tomer KROS Series C Preferred Stock C - Conversion I −88 460 0
2020-04-13 2020-04-13 4 Kariv Tomer KROS Series C Preferred Stock C - Conversion I −163 612 0
2020-04-13 2020-04-13 4 Kariv Tomer KROS Series B-1 Preferred Stock C - Conversion I −68 654 0
2020-04-13 2020-04-13 4 Kariv Tomer KROS Series B-1 Preferred Stock C - Conversion I −91 538 0
2020-04-13 2020-04-13 4 Kariv Tomer KROS Series B-1 Preferred Stock C - Conversion I −82 425 0
2020-04-13 2020-04-13 4 Kariv Tomer KROS Series B-1 Preferred Stock C - Conversion I −169 307 0
2020-04-13 2020-04-13 4 Kariv Tomer KROS Series A Preferred Stock C - Conversion I −737 226 0
2020-04-13 2020-04-13 4 Kariv Tomer KROS Series A Preferred Stock C - Conversion I −663 825 0
2020-04-13 2020-04-13 4 Kariv Tomer KROS Series A Preferred Stock C - Conversion I −1 363 542 0
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock P - Purchase I 16,0000 43 750 700 149 262
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock P - Purchase I 16,0000 105 000 1 680 1 213 926
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock P - Purchase I 16,0000 94 546 1 513 1 109 802
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock P - Purchase I 16,0000 194 203 3 107 2 261 517
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock C - Conversion I 36 858 105 512
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock C - Conversion I 79 653 1 108 926
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock C - Conversion I 88 460 1 015 256
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock C - Conversion I 163 612 2 067 314
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock C - Conversion I 68 654 68 654
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock C - Conversion I 91 538 1 029 273
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock C - Conversion I 82 425 926 796
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock C - Conversion I 169 307 1 903 702
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock C - Conversion I 737 226 937 735
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock C - Conversion I 663 825 844 371
2020-04-13 2020-04-13 4 Kariv Tomer KROS Common Stock C - Conversion I 1 363 542 1 734 395
2020-04-13 2020-04-13 4 Knowles Julius KROS Series C Preferred Stock C - Conversion I −44 676 0
2020-04-13 2020-04-13 4 Knowles Julius KROS Series C Preferred Stock C - Conversion I −67 015 0
2020-04-13 2020-04-13 4 Knowles Julius KROS Series B-1 Preferred Stock C - Conversion I −137 308 0
2020-04-13 2020-04-13 4 Knowles Julius KROS Series B-1 Preferred Stock C - Conversion I −205 962 0
2020-04-13 2020-04-13 4 Knowles Julius KROS Series A Preferred Stock C - Conversion I −184 305 0
2020-04-13 2020-04-13 4 Knowles Julius KROS Series A Preferred Stock C - Conversion I −276 459 0
2020-04-13 2020-04-13 4 Knowles Julius KROS Common Stock C - Conversion I 44 676 458 442
2020-04-13 2020-04-13 4 Knowles Julius KROS Common Stock C - Conversion I 67 015 687 665
2020-04-13 2020-04-13 4 Knowles Julius KROS Common Stock C - Conversion I 137 308 413 766
2020-04-13 2020-04-13 4 Knowles Julius KROS Common Stock C - Conversion I 205 962 620 650
2020-04-13 2020-04-13 4 Knowles Julius KROS Common Stock C - Conversion I 184 305 276 458
2020-04-13 2020-04-13 4 Knowles Julius KROS Common Stock C - Conversion I 276 459 414 688
2020-04-13 2020-04-13 4 Lazarus Alon KROS Series C Preferred Stock C - Conversion I −167 537 0
2020-04-13 2020-04-13 4 Lazarus Alon KROS Series B-1 Preferred Stock C - Conversion I −343 270 0
2020-04-13 2020-04-13 4 Lazarus Alon KROS Series A Preferred Stock C - Conversion I −1 382 295 0
2020-04-13 2020-04-13 4 Lazarus Alon KROS Common Stock P - Purchase I 16,0000 120 000 1 920 2 013 102
2020-04-13 2020-04-13 4 Lazarus Alon KROS Common Stock C - Conversion I 167 537 1 893 102
2020-04-13 2020-04-13 4 Lazarus Alon KROS Common Stock C - Conversion I 343 270 1 725 565
2020-04-13 2020-04-13 4 Lazarus Alon KROS Common Stock C - Conversion I 1 382 295 1 382 295
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Series C Preferred Stock C - Conversion I −36 858 0
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Series C Preferred Stock C - Conversion I −79 653 0
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Series C Preferred Stock C - Conversion I −88 460 0
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Series C Preferred Stock C - Conversion I −163 612 0
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Series B-1 Preferred Stock C - Conversion I −68 654 0
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Series B-1 Preferred Stock C - Conversion I −91 538 0
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Series B-1 Preferred Stock C - Conversion I −82 425 0
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Series B-1 Preferred Stock C - Conversion I −169 307 0
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Series A Preferred Stock C - Conversion I −737 226 0
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Series A Preferred Stock C - Conversion I −663 825 0
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Series A Preferred Stock C - Conversion I −1 363 542 0
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock P - Purchase I 16,0000 43 750 700 149 262
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock P - Purchase I 16,0000 105 000 1 680 1 213 926
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock P - Purchase I 16,0000 94 546 1 513 1 109 802
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock P - Purchase I 16,0000 194 203 3 107 2 261 517
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock C - Conversion I 36 858 105 512
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock C - Conversion I 79 653 1 108 926
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock C - Conversion I 88 460 1 015 256
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock C - Conversion I 163 612 2 067 314
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock C - Conversion I 68 654 68 654
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock C - Conversion I 91 538 1 029 273
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock C - Conversion I 82 425 926 796
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock C - Conversion I 169 307 1 903 702
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock C - Conversion I 737 226 937 735
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock C - Conversion I 663 825 844 371
2020-04-13 2020-04-13 4 Nussbaum Ran KROS Common Stock C - Conversion I 1 363 542 1 734 395
2020-04-13 2020-04-13 4 ORBIMED ADVISORS LLC KROS Series C Preferred Stock C - Conversion I −148 922 0
2020-04-13 2020-04-13 4 ORBIMED ADVISORS LLC KROS Series C Preferred Stock C - Conversion I −744 612 0
2020-04-13 2020-04-13 4 ORBIMED ADVISORS LLC KROS Common Stock P - Purchase I 16,0000 375 200 6 003 1 119 812
2020-04-13 2020-04-13 4 ORBIMED ADVISORS LLC KROS Common Stock C - Conversion I 148 922 148 922
2020-04-13 2020-04-13 4 ORBIMED ADVISORS LLC KROS Common Stock C - Conversion I 744 612 744 612
2020-04-08 2020-04-07 4 Lachey Jennifer KROS Employee Stock Option (right to buy) A - Award D 16,00 241 222 241 222
2020-04-08 2020-04-07 4 Ordonez Claudia KROS Employee Stock Option (right to buy) A - Award D 16,00 18 430 18 430
2020-04-08 2020-04-07 4 Regnante Keith KROS Employee Stock Option (right to buy) A - Award D 16,00 133 622 133 622
2020-04-08 2020-04-07 4 Regnante Keith KROS Employee Stock Option (right to buy) A - Award D 16,00 18 430 18 430
2020-04-08 2020-04-07 4 Seehra Jasbir KROS Employee Stock Option (right to buy) A - Award D 16,00 696 569 696 569
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 932 454
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 1 122 761
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 932 454
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 1 122 761
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 1 122 761
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 932 454
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 952 417
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 1 122 761
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 952 417
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 1 122 761
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 932 454
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 952 417
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 1 122 761
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 932 454
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 952 417
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 952 417
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 1 122 761
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 932 454
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 952 417
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 932 454
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 952 417
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 932 454
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 952 417
2020-04-07 3 Pontifax Late Stage GP Ltd. KROS Common Stock I 1 122 761
2020-04-07 3 Seehra Jasbir KROS Common Stock D 425 374
2020-04-07 3 Seehra Jasbir KROS Common Stock D 425 374
2020-04-07 3 Seehra Jasbir KROS Common Stock D 425 374
2020-04-07 3 Knowles Julius KROS Common Stock I 368 611
2020-04-07 3 Knowles Julius KROS Common Stock I 322 535
2020-04-07 3 Knowles Julius KROS Common Stock I 322 535
2020-04-07 3 Knowles Julius KROS Common Stock I 368 611
2020-04-07 3 Knowles Julius KROS Common Stock I 368 611
2020-04-07 3 Knowles Julius KROS Common Stock I 322 535
2020-04-07 3 Lachey Jennifer KROS Common Stock D 55 982
2020-04-07 3 Lachey Jennifer KROS Common Stock D 55 982
2020-04-07 3 Lachey Jennifer KROS Common Stock D 55 982
2020-04-07 3 Lazarus Alon KROS Common Stock D 46 076
2020-04-07 3 Lazarus Alon KROS Common Stock D 46 076
2020-04-07 3 Lazarus Alon KROS Common Stock D 46 076
2020-04-07 3 Nussbaum Ran KROS Common Stock I 952 417
2020-04-07 3 Nussbaum Ran KROS Common Stock I 932 454
2020-04-07 3 Nussbaum Ran KROS Common Stock I 1 122 761
2020-04-07 3 Nussbaum Ran KROS Common Stock I 932 454
2020-04-07 3 Nussbaum Ran KROS Common Stock I 1 122 761
2020-04-07 3 Nussbaum Ran KROS Common Stock I 952 417
2020-04-07 3 Nussbaum Ran KROS Common Stock I 952 417
2020-04-07 3 Nussbaum Ran KROS Common Stock I 932 454
2020-04-07 3 Nussbaum Ran KROS Common Stock I 1 122 761
2020-04-07 3 Kariv Tomer KROS Common Stock I 932 454
2020-04-07 3 Kariv Tomer KROS Common Stock I 932 454
2020-04-07 3 Kariv Tomer KROS Common Stock I 952 417
2020-04-07 3 Kariv Tomer KROS Common Stock I 1 122 761
2020-04-07 3 Kariv Tomer KROS Common Stock I 932 454
2020-04-07 3 Kariv Tomer KROS Common Stock I 952 417
2020-04-07 3 Kariv Tomer KROS Common Stock I 952 417
2020-04-07 3 Kariv Tomer KROS Common Stock I 1 122 761
2020-04-07 3 Kariv Tomer KROS Common Stock I 1 122 761
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista